These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30901488)

  • 1. Prevalence and severity of symptoms suggestive of gastroparesis in prodromal dementia with Lewy bodies.
    Durcan R; Donaghy PC; Barnett NA; Olsen K; Yarnall AJ; Taylor JP; McKeith I; O'Brien JT; Thomas AJ
    Int J Geriatr Psychiatry; 2019 Jul; 34(7):990-998. PubMed ID: 30901488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies.
    Thomas AJ; Donaghy P; Roberts G; Colloby SJ; Barnett NA; Petrides G; Lloyd J; Olsen K; Taylor JP; McKeith I; O'Brien JT
    Psychol Med; 2019 Feb; 49(3):396-402. PubMed ID: 29692275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies.
    Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; Colloby SJ; Lloyd J; Petrides G; McKeith IG; Thomas AJ
    Psychol Med; 2018 Oct; 48(14):2384-2390. PubMed ID: 29362011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Nigrostriatal Dopaminergic Imaging in Mild Cognitive Impairment With Lewy Bodies, Alzheimer Disease, and Age-Matched Controls.
    Durcan R; Roberts G; Hamilton CA; Donaghy PC; Howe K; Colloby SJ; Allan LM; Firbank M; Lawley S; Petrides GS; Lloyd JJ; Taylor JP; O'Brien JT; Thomas AJ
    Neurology; 2023 Sep; 101(12):e1196-e1205. PubMed ID: 37524532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
    O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
    Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic value of EEG in prodromal dementia with Lewy bodies.
    van der Zande JJ; Gouw AA; van Steenoven I; van de Beek M; Scheltens P; Stam CJ; Lemstra AW
    Neurology; 2020 Aug; 95(6):e662-e670. PubMed ID: 32636325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies.
    Walker Z; Cummings JL
    Alzheimers Dement; 2012 Jan; 8(1):74-83. PubMed ID: 22024052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms associated with Lewy body disease in mild cognitive impairment.
    Donaghy PC; Barnett N; Olsen K; Taylor JP; McKeith IG; O'Brien JT; Thomas AJ
    Int J Geriatr Psychiatry; 2017 Nov; 32(11):1163-1171. PubMed ID: 28556415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ; Firbank MJ; Pakrasi S; Lloyd JJ; Driver I; McKeith IG; Williams ED; O'Brien JT
    Int Psychogeriatr; 2008 Dec; 20(6):1124-40. PubMed ID: 18752700
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kasanuki K; Iseki E; Ota K; Kondo D; Ichimiya Y; Sato K; Arai H
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):358-365. PubMed ID: 27480759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
    Roberts G; Durcan R; Donaghy PC; Lawley S; Ciafone J; Hamilton CA; Colloby SJ; Firbank MJ; Allan L; Barnett N; Barker S; Howe K; Ali T; Petrides GS; Lloyd J; Taylor JP; O'Brien J; Thomas AJ
    Neurology; 2021 Jun; 96(23):e2801-e2811. PubMed ID: 33883238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT.
    Morgan S; Kemp P; Booij J; Costa DC; Padayachee S; Lee L; Barber C; Carter J; Walker Z
    J Neurol Neurosurg Psychiatry; 2012 Nov; 83(11):1063-70. PubMed ID: 22869921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
    McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
    Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
    Shimizu S; Kanetaka H; Hirao K; Fukasawa R; Namioka N; Hatanaka H; Hirose D; Umahara T; Sakurai H; Hanyu H
    Geriatr Gerontol Int; 2017 May; 17(5):819-824. PubMed ID: 27138074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing Nigrostriatal Dopaminergic Pathways
    Hansen N; Lange C; Timäus C; Wiltfang J; Bouter C
    Front Aging Neurosci; 2021; 13():672956. PubMed ID: 34234666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of dopaminergic imaging as a biomarker for mild cognitive impairment with Lewy bodies.
    Roberts G; Donaghy PC; Lloyd J; Durcan R; Petrides G; Colloby SJ; Lawley S; Ciafone J; Hamilton CA; Firbank M; Allan L; Barnett N; Barker S; Olsen K; Howe K; Ali T; Taylor JP; O'Brien J; Thomas AJ
    Br J Psychiatry; 2021 May; 218(5):276-282. PubMed ID: 33355065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prodromal dementia with Lewy bodies.
    Donaghy PC; O'Brien JT; Thomas AJ
    Psychol Med; 2015 Jan; 45(2):259-68. PubMed ID: 25066469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency, Severity, and Duration of Autonomic Symptoms in Patients of Prodromal Dementia with Lewy Bodies.
    Liu S; Liu C; Hu W; Ji Y
    J Alzheimers Dis; 2022; 89(3):923-929. PubMed ID: 35988221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High specificity of MMSE pentagon scoring for diagnosis of prodromal dementia with Lewy bodies.
    Cagnin A; Bussè C; Jelcic N; Gnoato F; Mitolo M; Caffarra P
    Parkinsonism Relat Disord; 2015 Mar; 21(3):303-5. PubMed ID: 25547859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.